Thermal image scanning for influenza border screening: results of an airport screening study.
BACKGROUND
Infrared thermal image scanners (ITIS) appear an attractive option for the mass screening of travellers for influenza, but there are no published data on their performance in airports.


METHODS
ITIS was used to measure cutaneous temperature in 1275 airline travellers who had agreed to tympanic temperature measurement and respiratory sampling. The prediction by ITIS of tympanic temperature (37.8°C and 37.5°C) and of influenza infection was assessed using Receiver Operating Characteristic (ROC) curves and estimated sensitivity, specificity and positive predictive value (PPV).


RESULTS
Using front of face ITIS for prediction of tympanic temperature ≥37.8°C, the area under the ROC curve was 0.86 (95%CI 0.75-0.97) and setting sensitivity at 86% gave specificity of 71%. The PPV in this population of travellers, of whom 0.5% were febrile using this definition, was 1.5%. We identified influenza virus infection in 30 travellers (3 Type A and 27 Type B). For ITIS prediction of influenza infection the area under the ROC curve was 0.66 (0.56-0.75), a sensitivity of 87% gave specificity of 39%, and PPV of 2.8%. None of the 30 influenza-positive travellers had tympanic temperature ≥37.8°C at screening (95%CI 0% to 12%); three had no influenza symptoms.


CONCLUSIONS
ITIS performed moderately well in detecting fever but in this study, during a seasonal epidemic of predominantly influenza type B, the proportion of influenza-infected travellers who were febrile was low and ITIS were not much better than chance at identifying travellers likely to be influenza-infected. Although febrile illness is more common in influenza A infections than influenza B infections, many influenza A infections are afebrile. Our findings therefore suggest that ITIS is unlikely to be effective for entry screening of travellers to detect influenza infection with the intention of preventing entry of the virus into a country.
Department of Preventive and Social Medicine, University of Otago, Dunedin, New Zealand. patricia.priest@otago.ac.nz
Patricia C
PC
Priest
Alasdair R
AR
Duncan
Lance C
LC
Jennings
Michael G
MG
Baker
D059028:Airports; D005334:Fever / Q000175:diagnosis; D006801:Humans; D007251:Influenza, Human / Q000175:diagnosis* / Q000517:prevention & control; D007259:Infrared Rays; D008403:Mass Screening / Q000379:methods*; D012372:ROC Curve; D012881:Skin Temperature
Am J Public Health. 2009 Oct;99 Suppl 2:S360-2
19797749
BMJ. 1994 Jul 16;309(6948):188
8044101
Can Commun Dis Rep. 2004 Oct 1;30(19):165-7
15499826
Lancet. 2009 Nov 14;374(9702):1673
19914506
J Travel Med. 2004 Sep-Oct;11(5):273-9
15544710
Infect Control Hosp Epidemiol. 2004 Dec;25(12):1109-11
15636300
Am J Epidemiol. 2008 Apr 1;167(7):775-85
18230677
Emerg Infect Dis. 2010 Jan;16(1):21-6
20031038
Clin Infect Dis. 2000 Nov;31(5):1166-9
11073747
Emerg Infect Dis. 2008 Aug;14(8):1255-8
18680649
BMC Infect Dis. 2010 Mar 30;10:82
20353566
Microvasc Res. 2004 Sep;68(2):104-9
15313119
Emerg Infect Dis. 2005 Jan;11(1):6-10
15705315
Euro Surveill. 2009 Feb 12;14(6):
19215720
Arch Intern Med. 2000 Nov 27;160(21):3243-7
11088084
BMJ. 2009 Sep 21;339:b3675
19773323
Aust N Z J Public Health. 2010 Feb;34(1):5-10
20920098
Arch Intern Med. 2001 Sep 24;161(17):2116-22
11570941
Emerg Infect Dis. 2004 Nov;10(11):1900-6
15550198
N Engl J Med. 2009 Dec 24;361(26):2507-17
20007555
BMJ. 2005 Nov 26;331(7527):1242-3
16176938